Author

Jacques J. Bergman

What I regretted most in the treatment of Barrett's early cancer
What I regretted most in the treatment of Barrett's early cancer

Jacques J. Bergman

How to create AI for Barrett's oesophagus and how to integrate it in its management
How to create AI for Barrett's oesophagus and how to integrate it in its management

Jacques J. Bergman  et al.

Mistakes in... endoscopic treatment of Barrett oesophagus neoplasia
Mistakes in... endoscopic treatment of Barrett oesophagus neoplasia

Jacques J. Bergman  et al.

SINGLE WAVELENGTH ENDOSCOPY FOR THE ASSESSMENT OF BARRETT’S OESOPHAGUS: EXPERT AND NON-EXPERT OPTICAL DIAGNOSIS USING DIFFERENT IMAGING TECHNIQUES
SINGLE WAVELENGTH ENDOSCOPY FOR THE ASSESSMENT OF BARRETT’S OESOPHAGUS: EXPERT AND NON-EXPERT OPTICAL DIAGNOSIS USING DIFFERENT IMAGING TECHNIQUES

Jacques J. Bergman  et al.

INITIAL EXPERIENCES WITH A VACUUM-STENT AS NOVEL TREATMENT OPTION FOR TRANSMURAL DEFECTS IN THE UPPER GASTRO-INTESTINAL TRACT: A SINGLE-CENTER CASE SERIES
INITIAL EXPERIENCES WITH A VACUUM-STENT AS NOVEL TREATMENT OPTION FOR TRANSMURAL DEFECTS IN THE UPPER GASTRO-INTESTINAL TRACT: A SINGLE-CENTER CASE SERIES

Jacques J. Bergman  et al.

ENDOSCOPIC ERADICATION THERAPY WITH MULTIFOCAL CRYOBALLOON ABLATION FOR BARRETT’S ESOPHAGUS RELATED NEOPLASIA
ENDOSCOPIC ERADICATION THERAPY WITH MULTIFOCAL CRYOBALLOON ABLATION FOR BARRETT’S ESOPHAGUS RELATED NEOPLASIA

Jacques J. Bergman  et al.

ENDOSCOPIC VACUUM THERAPY FOR PATIENTS WITH ANASTOMOTIC LEAKAGE AFTER ESOPHAGO-GASTRIC SURGERY
ENDOSCOPIC VACUUM THERAPY FOR PATIENTS WITH ANASTOMOTIC LEAKAGE AFTER ESOPHAGO-GASTRIC SURGERY

Jacques J. Bergman  et al.

FOCAL C2 CRYOBALLOON (TM) ABLATION WITH 8SEC DOSE HAS SIMILAR EFFICACY AS 10SEC FOR TREATMENT OF BARRETT’S ESOPHAGUS RELATED NEOPLASIA
FOCAL C2 CRYOBALLOON (TM) ABLATION WITH 8SEC DOSE HAS SIMILAR EFFICACY AS 10SEC FOR TREATMENT OF BARRETT’S ESOPHAGUS RELATED NEOPLASIA

Jacques J. Bergman  et al.

LONG-TERM PROGNOSIS OF WESTERN PATIENTS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA IS LIMITED DUE TO COMPETING MORTALITY
LONG-TERM PROGNOSIS OF WESTERN PATIENTS AFTER ENDOSCOPIC SUBMUCOSAL DISSECTION FOR EARLY ESOPHAGEAL SQUAMOUS CELL CARCINOMA IS LIMITED DUE TO COMPETING MORTALITY

Jacques J. Bergman  et al.

CHANGES IN INCRETINS, BILE ACIDS AND THE MICROBIOME AFTER DUODENAL MUCOSAL RESURFACING IN PATIENTS WITH TYPE 2 DIABETES
CHANGES IN INCRETINS, BILE ACIDS AND THE MICROBIOME AFTER DUODENAL MUCOSAL RESURFACING IN PATIENTS WITH TYPE 2 DIABETES

Jacques J. Bergman  et al.

A COMPUTER-AIDED DIAGNOSIS (CADX) SYSTEM FOR CHARACTERIZATION OF BARRETT’S NEOPLASIA
A COMPUTER-AIDED DIAGNOSIS (CADX) SYSTEM FOR CHARACTERIZATION OF BARRETT’S NEOPLASIA

Jacques J. Bergman  et al.

A COMPUTER AIDED DETECTION SYSTEM FOR BARRETT'S NEOPLASIA IMPROVES NEOPLASIA DETECTION
A COMPUTER AIDED DETECTION SYSTEM FOR BARRETT'S NEOPLASIA IMPROVES NEOPLASIA DETECTION

Jacques J. Bergman  et al.

LINKED COLOR IMAGING IMPROVES IDENTIFICATION OF EARLY GASTRIC CANCER FOR BOTH EXPERT AND NON-EXPERT ENDOSCOPISTS
LINKED COLOR IMAGING IMPROVES IDENTIFICATION OF EARLY GASTRIC CANCER FOR BOTH EXPERT AND NON-EXPERT ENDOSCOPISTS

Jacques J. Bergman  et al.

Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement
Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement

Jacques J. Bergman  et al.

INTEGRATED FRAME INFORMATIVENESS ASSESSMENT ALGORITHM FOR BARRETT’S NEOPLASIA
INTEGRATED FRAME INFORMATIVENESS ASSESSMENT ALGORITHM FOR BARRETT’S NEOPLASIA

Jacques J. Bergman  et al.

MIND THE (DOMAIN) GAP: EVALUATING AND IMPROVING ROBUSTNESS OF ARTIFICIAL INTELLIGENCE SYSTEMS IN ENDOSCOPY
MIND THE (DOMAIN) GAP: EVALUATING AND IMPROVING ROBUSTNESS OF ARTIFICIAL INTELLIGENCE SYSTEMS IN ENDOSCOPY

Jacques J. Bergman  et al.

RANDOM BIOPSIES FROM THE GASTRO-ESOPHAGEAL JUNCTION AFTER COMPLETE ERADICATION OF BARRETT’S ESOPHAGUS: UTILE OR FUTILE?
RANDOM BIOPSIES FROM THE GASTRO-ESOPHAGEAL JUNCTION AFTER COMPLETE ERADICATION OF BARRETT’S ESOPHAGUS: UTILE OR FUTILE?

Jacques J. Bergman  et al.

THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES
THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES

Jacques J. Bergman  et al.

ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES
ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES

Jacques J. Bergman  et al.

HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS
HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS

Jacques J. Bergman  et al.

Item 1 - 20 / 26
1
2